The Middle East region, particularly Saudi Arabia, the United Arab Emirates (UAE), and Qatar, is emerging as a growing hub for biotechnology research and development in neurodegeneration. These countries are investing heavily in healthcare and life sciences as part of their national vision programs, with increasing focus on neurological diseases including Alzheimer's disease and Parkinson's disease.
SABIC is one of the largest petrochemical companies in the world and has expanded into life sciences and healthcare innovations.
- Headquarters: Riyadh, Saudi Arabia
- Focus: Healthcare materials, drug delivery
- Activities: Supporting research in neurodegenerative disease diagnostics
SaudiVax is a Saudi Arabian biotechnology company focused on vaccine development and immunotherapeutics.
- Headquarters: Riyadh, Saudi Arabia
- Focus: Immunotherapeutics, vaccines
- Potential applications: Neurodegenerative disease immunotherapies
¶ King Abdullah University of Science and Technology (KAUST)
KAUST is a graduate-level research university that has established significant research programs in life sciences and biotechnology.
- Location: Thuwal, Saudi Arabia
- Focus: Computational biology, genomics, neuroscience
- Research: Alzheimer's and Parkinson's disease mechanisms
- Collaborations: International partnerships with leading research institutions
¶ King Faisal Specialist Hospital and Research Centre
KFSH&RC is a leading research hospital with significant neuroscience research programs.
- Location: Riyadh, Saudi Arabia
- Focus: Neurology, neurosurgery, neurodegenerative diseases
- Research: Clinical trials for neurological disorders
SPIMACO is a Saudi pharmaceutical company developing treatments for various diseases.
- Headquarters: Riyadh, Saudi Arabia
- Focus: Pharmaceutical manufacturing, drug development
- Potential: CNS drug development programs
Dubai Healthcare City is a free economic zone dedicated to healthcare and life sciences.
- Location: Dubai, UAE
- Focus: Healthcare services, medical research
- Companies: Multiple biotech and pharmaceutical companies
- Research: Neurology and neuroscience programs
The Abu Dhabi Department of Health supports research in neurodegenerative diseases through various initiatives.
- Location: Abu Dhabi, UAE
- Focus: Healthcare innovation, precision medicine
- Programs: Neuroscience research initiatives
M42 is a tech-enabled healthcare company operating in the UAE with significant research capabilities.
- Headquarters: Abu Dhabi, UAE
- Focus: Precision medicine, genomics
- Research: Neurological disease genetics and diagnostics
Emirates Health Services (formerly Emirates Medical Association) supports healthcare innovation in the UAE.
- Location: Dubai, UAE
- Focus: Healthcare delivery, medical research
- Programs: Neuroscience and neurology programs
¶ UAE University and Khalifa University
Leading UAE universities conduct neuroscience research with potential biotech applications.
- Locations: Al Ain, Abu Dhabi, UAE
- Focus: Neuroscience research, biotechnology
- Programs: Alzheimer's and Parkinson's disease research
Qatar Foundation is a non-profit organization supporting education and research in Qatar.
- Location: Doha, Qatar
- Focus: Research, education, healthcare
- Initiatives: Life sciences and health research
QBRI is a leading research institute in Qatar focused on diabetes, cancer, and neurological disorders.
- Location: Doha, Qatar
- Focus: Diabetes, cancer, neurodegenerative diseases
- Research: Parkinson's disease, Alzheimer's disease
- Facilities: State-of-the-art research laboratories
HMC is the main healthcare provider in Qatar with significant research capabilities.
- Location: Doha, Qatar
- Focus: Healthcare delivery, medical research
- Programs: Neurology and neuroscience clinical research
Qatar University conducts research in life sciences and biotechnology.
- Location: Doha, Qatar
- Focus: Biological sciences, chemistry
- Research: Biomedical research including neuroscience
| Area |
Description |
| Investment |
Significant government funding for healthcare R&D |
| Infrastructure |
Modern research facilities and hospitals |
| Vision Programs |
National strategies supporting life sciences |
| Strategic Location |
Gateway between Asia, Europe, and Africa |
- Emerging biotech ecosystem (compared to US/Europe)
- Limited number of dedicated neurodegeneration biotech companies
- Early-stage research translation
| Institution/Company |
Focus Area |
Stage |
| KAUST |
Neuroscience research |
Research |
| QBRI |
Neurodegeneration |
Research |
| KFSH&RC |
Clinical trials |
Clinical |
| SaudiVax |
Immunotherapeutics |
Discovery |
¶ Investment and Funding
The Middle East region is increasing investment in biotechnology:
- Saudi Vision 2030 includes significant healthcare investment
- UAE National Innovation Strategy supports life sciences
- Qatar Research, Development, and Innovation Strategy
The Middle East region is positioning itself as a growing hub for biotech innovation in neurodegeneration through:
- Expansion of research infrastructure
- International collaborations
- Government-supported innovation initiatives
- Focus on precision medicine and genomics